NDATOPICALSPONGE
Approved
Sep 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DURAPREP is a topical antiseptic sponge containing iodine povacrylex and isopropyl alcohol, indicated for skin antisepsis prior to surgical procedures. It provides rapid and sustained antimicrobial activity to reduce the risk of surgical site infections. The combination formulation leverages iodine's broad-spectrum antimicrobial efficacy with alcohol's rapid bactericidal action.
LOE Approaching
As DURAPREP approaches loss of exclusivity, commercial teams face declining revenue and shrinking field presence, signaling potential workforce restructuring.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DURAPREP offers limited career growth prospects given its approaching loss of exclusivity and minimal linked job openings. Roles on this product are primarily focused on defending market share and managing decline rather than driving innovation or expansion.
Brand ManagerField Sales Representative
Worked on DURAPREP at Solventum? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.